Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex pays $105M to kick off gene editing pact with CRISPR Therapeutics
Vertex pays $105M to kick off gene editing pact with CRISPR Therapeutics
Vertex pays $105M to kick off gene editing pact with CRISPR Therapeutics
Submitted by
admin
on October 26, 2015 - 8:47am
Source:
Fierce Biotech
News Tags:
Vertex Pharmaceuticals
gene editing
CRISPR Therapeutics
Headline:
Vertex pays $105M to kick off gene editing pact with CRISPR Therapeutics
Do Not Allow Advertisers to Use My Personal information
